Acrobiosystems for English
icon_bulk_orderBulk inquiry/Quick order
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > S1PR5


Brief Information

Name:Sphingosine 1-phosphate receptor 5
Target Synonym:Sphingosine 1-phosphate receptor 5,S1P receptor 5,S1PR5,Sphingosine-1-Phosphate Receptor 5,Endothelial Differentiation, Sphingolipid G-Protein-Coupled Receptor, 8,Endothelial Differentiation G-Protein-Coupled Receptor 8,Sphingosine 1-Phosphate Receptor Edg-8,S1P Receptor Edg-8,EDG8,S1P5,Sphingosine 1-Phosphate Receptor EDG8,SPPR-1,SPPR-2,Edg-8
Number of Launched Drugs:5
Number of Drugs in Clinical Trials:0
Lastest Research Phase:Approved

Product ListCompare or Buy

By Product Status:
By Product Category:
By Species:
By Conjugate:
Cat. No. Species Product Description Structure Purity Feature
S15-H52P7 Human Human S1PR5 / EDG8 Full Length Protein (VLP)
ACRO Quality

Public Drug Information

Name Research Code Research Phase Company First Brand Name First Approved Country First Indication First Approved Company First Approved Date Indications Clinical Trials
Fingolimod Hydrochloride FTY-720A; TDI-132; FTY-720 Approved Novartis Pharma Ag Gilenia, Imusera, 捷灵亚, Gilenya United States Multiple Sclerosis Novartis Pharma Ag 2010-09-21 Cerebral Hemorrhage, Traumatic; Amyotrophic Lateral Sclerosis; Uveitis; Asthma; Intracranial Hemorrhage, Hypertensive; Brain Edema; Hypesthesia; Breast Neoplasms; Optic Neuritis; Multiple Sclerosis; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Cerebral Hemorrhage; Renal Insufficiency; Schizophrenia; Rett Syndrome; Pain; Intracranial Hemorrhages; Rejection of renal transplantation; Peripheral Nervous System Diseases; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating Details
Ozanimod hydrochloride CYM-5442; RPC-1063 Approved The Scripps Research Institute Inc 热珀西亚, Zeposia United States Multiple Sclerosis Bristol-Myers Squibb Company 2020-03-25 Multiple Sclerosis, Relapsing-Remitting; Digestive System Diseases; Gram-Negative Bacterial Infections; Coronavirus Disease 2019 (COVID-19); Multiple Sclerosis; Liver Diseases; Colitis, Ulcerative; Crohn Disease Details
Etrasimod arginine APD-334; MXE5EMA09L; APD-334 L-Arginine; PF-07915503 Approved Arena Pharmaceuticals Inc VELSIPITY United States Colitis, Ulcerative Pfizer Inc 2023-10-12 Inflammatory Bowel Diseases; Pyoderma Gangrenosum; Alopecia Areata; Intraabdominal Infections; Cholangitis, Sclerosing; Eosinophilic Esophagitis; Colitis, Ulcerative; Dermatitis, Atopic; Eczema; Crohn Disease Details
Fingolimod lauryl sulfate Approved Handa Neuroscience LLC Tascenso ODT United States Multiple Sclerosis Handa Neuroscience LLC 2021-10-18 Multiple Sclerosis, Relapsing-Remitting; Multiple Sclerosis Details
Siponimod NVP-BAF312-AEA; BAF-312; NVP-BAF312-NX Approved Novartis Pharma Ag Mayzent United States Multiple Sclerosis Novartis Pharma Ag 2019-03-26 Multiple Sclerosis, Relapsing-Remitting; Polymyositis; Cerebral Hemorrhage; Dermatomyositis; Multiple Sclerosis; Multiple Sclerosis, Chronic Progressive; Stroke; Hepatic Insufficiency Details

This web search service is supported by Google Inc.

Call us
Call us
North America:
+1 800-810-0816 (Toll Free)
Asia & Pacific:
+86 400-682-2521
+1 888-377-6111
1 Innovation Way, Newark, DE 19711, USA

Leave a message